Janney Montgomery Scott LLC Buys 7,983 Shares of The Clorox Company (NYSE:CLX)

Janney Montgomery Scott LLC grew its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 7.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 109,275 shares of the company's stock after buying an additional 7,983 shares during the period. Janney Montgomery Scott LLC owned 0.09% of Clorox worth $17,747,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in CLX. Brooklyn Investment Group raised its holdings in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC bought a new stake in Clorox during the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC lifted its holdings in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Quarry LP lifted its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC purchased a new stake in Clorox during the 3rd quarter valued at approximately $48,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Trading Down 1.1 %

Shares of CLX stock traded down $1.71 during trading hours on Friday, reaching $159.12. 948,374 shares of the stock were exchanged, compared to its average volume of 787,854. The firm has a market capitalization of $19.70 billion, a price-to-earnings ratio of 55.44, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company's 50-day moving average price is $163.66 and its 200-day moving average price is $157.50. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The company's quarterly revenue was up 27.0% on a year-over-year basis. As a group, equities analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.07%. Clorox's payout ratio is 170.04%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CLX. StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and boosted their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and lifted their target price for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. JPMorgan Chase & Co. increased their price target on Clorox from $167.00 to $171.00 and gave the company a "neutral" rating in a research note on Thursday, January 16th. Finally, Evercore ISI decreased their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a report on Monday, October 14th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.